Back to Agenda
Session 6: Advancing Regulatory Pathways for New Frontiers in Molecular Testing, including Next Generation Sequencing
Session Chair(s)
Jennifer Dudinak-Dickson, PharmD
Senior Vice President, Global Regulatory Sciences
Bristol Myers Squibb , United States
Speaker(s)
Application of Multi-Analyte Testing in Clinical Development: Practical Considerations
Anne-Marie Martin, PhD
GlaxoSmithKline, United States
Senior Vice President, Global Head of Experimental Medicine
Regulatory Perspective of the Diagnostics Manufacturer – NGS for Personalized Medicine
Lynne McBride
Thermo Fisher Scientific, United States
Director Regulatory Affairs & Clinical Life Sciences Solution
Regulatory Considerations for Multiplex Companion Diagnostic Test Development from the Pharmaceutial Perspective
Michael Benecky, PhD
UCB, United States
Senior Director, Global Regulatory Affairs
Emerging Regulatory Paradigm for NGS
Xueying Sharon Liang, MD, PhD
FDA, United States
Epidemiologist, CDRH
Have an account?